ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Taxation/Internal Revenue Code TAX

Unassigned legislative proposals regarding tax matters, including issues related to deficit reduction, repatriation, and transfer pricing

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

S. 525 and related legislative proposals regarding prescription drug importation and safety issues

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: S. 525 (111th)

Pharmacy PHA

FDA Appropriations issues, including issues likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) V (currently unassigned) General FDA Issues

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Participate in executive branch discussions regarding intellectual property issues arising in foreign countries

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4899 (111th), S. 3677 (111th)

Health Issues HCR

HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to healthcare reform legislation and implementation, including the newly-created Independent Payment Advisory Board, evidence-based medicine, and health information technology HR 6331 - issues related to antibiotic development legislation Monitoring and discussing issues under discussion by the President's Deficit Commission, including recommendations regarding the Independent Payment Advisory Board and Medicare Part D rebates (unassigned) Monitoring implementation of existing legislative and regulatory proposals and possible future legislative developments regarding Health Information Technology and Personal Health Records (unassigned) Participate in executive branch discussions regarding pharmaceutical pricing and reimbursement regimes in foreign countries

Contacted: State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 4872 (111th), H.R. 3590 (111th), H.R. 6331 (111th)

Medicare/Medicaid MMM

HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to pharmaceutical price calculation and reporting HR 3590, S 1790, HR 4872 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including issues related to Medicare Part D Coverage Gap Program

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3590 (111th), H.R. 4872 (111th)